Rashmi Samant resigns as Oxford Student Union president-elect amidst row over controversial social media posts
Some of Samant’s old social media were branded as “racist” and “insensitive”. She has since left for India to be with her family and many of her social media accounts have been deleted
Over 160 L COVID-19 vaccine doses procured so far, but beneficiaries below target due to hesitancy, govt tells LS
Giving out the details of the number of vaccines already procured by the government, Minister of State for Health Ashwini Choubey said the total cost of procurement of above mentioned doses of vaccines is Rs 350.25 crore
Doses of the vaccine, Covishield, will initially be shipped to 60 consignee points and will then be distributed to various vaccination centres across India
The prime minister is visiting the top vaccine hubs to 'get a first-hand perspective of the roadmap in India's endeavour to vaccinate its citizens', said the PMO
Oxford-AstraZeneca COVID-19 vaccine will be available at cost price across world, says pharma head Olivier Nataf
Unlike the two vaccines produced by Moderna and Pfizer-BioNTech, which require ultra-cold storage, the AstraZeneca vaccine can be kept in the conventional fridge used to store vaccines around the world
Additionally, the drug manufacturer said that another regiment of a half dose, followed by a full dose at least one month apart was 90 percent effective
Morris was a prolific and accomplished author and journalist who wrote dozens of books in a variety of genres and was a first-hand witness to history.
Oxford COVID-19 vaccine performing as 'expected', successfully induces immune response, says independent study
The vaccine, ChAdOx1 nCoV-19 and also known as AZD1222, is considered among the most advanced in the worldwide hunt for a viable vaccine against the novel coronavirus
Volunteer in Oxford-AstraZeneca COVID-19 vaccine trial dies in Brazil; officials say testing to continue
Oxford confirmed the plan to keep testing, saying in a statement that after careful assessment 'there have been no concerns about safety of the clinical trial'
Coronavirus Vaccine Tracker: Serum Institute of India pauses clinical trials after DCGI show-cause notice
The Pune-based company said that it's reviewing the situation and pausing India trials of the COVID-19 vaccine candidate till AstraZeneca restarts the trials
Phase 2 trials: Vital signs of volunteers in Pune administered with Oxford COVID-19 vaccine normal, say doctors
Serum Institute of India has signed an agreement to manufacture a potential COVID-19 vaccine developed by Oxford University in collaboration with AstraZeneca
Pune's Bharti Vidyapeeth Medical College to begin phase 2 trials of Oxford COVID-19 vaccine from tomorrow
The institution, which is one of the 17 sites chosen by Serum Institute of India to conduct the trials, has been given a target of enlisting 300 to 350 volunteers
COVID-19 vaccine to cost Rs 225 per dose in India says Serum Institute, will be made available to 92 nations
Serum Institute partners with Gavi and Bill & Melinda Gates Foundation to manufacture, deliver of up to 100 million doses of COVID-19 vaccines to India, other low and middle-income countries.
Serum Institute asked to revise protocols for Phase 2, 3 trials of Oxford COVID-19 vaccine candidate
The CDSCO expert panel also recommended that Pune-based firm's proposed clinical trial sites be distributed across India
Serum Institute of India has been chosen by Oxford University and its partner AstraZeneca to manufacture the COVID-19 vaccine
COVID-19 research roundup: Multiple potential vaccines show promise; doctors say hands-only CPR safe during pandemic
Hands-only CPR carries low risk of transmitting COVID-19, and bystanders witnessing a cardiac arrest shouldn't be afraid to perform it, doctors say.
Coronavirus LIVE Updates: Sharjeel Imam has tested positive for COVID-19, ANI reported. Delhi Police Special Cell had applied for his production warrant in Assam as he is lodged at Guwahati Central Jail and he was going to be presented before a Delhi Court on 25 July, but will not be produced now.
The 75 countries, which would finance the vaccines from public budgets, will partner with up to 90 poorer countries to provide them with access.
Oxford's vaccine offers ‘good duration of immunity’ to COVID-19 compared to no vaccine: lead researcher
The vaccine has been licensed to AstraZeneca and is in its Phase III of its human trials in the UK.
Aftermath of George Floyd killing: Across the pond, Britain grapples with its racist past, from town square to boardroom
Britain’s uneasy confrontation with its racist history moved from statues in town squares to corporate boardrooms this week, as two prominent British firms, Lloyd’s of London and Greene King, announced they would make amends for their involvement in the slave trade in the 18th and 19th centuries